Can-Fite BioPharma Ltd. Proceeds from Issuance of Warrants
Can-Fite BioPharma Ltd. (CANF) reported Proceeds from Issuance of Warrants of $6.71 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-26
| Period end | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|
| 2025-12-31 | $6.71M 20-F · filed 2026-03-26 | |
| 2025-06-30 | $825.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $4.49M 20-F · filed 2026-03-26 | |
| 2023-12-31 | $9.14M 20-F · filed 2026-03-26 | |
| 2023-06-30 | $1.00K 6-K · filed 2024-08-29 | |
| 2020-06-30 | $3.13M 6-K · filed 2021-08-26 |